and you Thank you, today's for Good Dan. conference thank afternoon, joining us call. for
to for Bill. passage I matters, of like would XXXX industry, to our critical the the some of our been which have regulatory Farm is comments at with industry so on Because the it start front since mind
pathway and statements inaction announcements CBD have disappointing. products. production support clear made as by FDA regulatory its are CBD. and for FDA Public the to and passing In Congress such Bill, Despite they sale a hemp of derivatives, Farm investigating the and that been hemp XXXX intent
has for clarity inaction has created looking uncertainty consumers regulatory our for chilled hurt industry, Federal and investment.
X areas several There regulation federal that regulation means. cover areas. for define our critical federal I'll does what industry? what mean are So
are The act safety. of area safety means insufficient they to hesitant is, said has first because critical regulation The FDA data.
safety safety. our Regulation know However, and consumer to public public and health way is we uncertainty further that for is all industry address products the compelling. data only in
liver growing Sciences of other our supplements is dietary industry studies from science, evidence, including hemp-derived levels by many food, that are data in of studies, evidence The XXXX, clearly especially including safe. published demonstrates which body at generally toxicity several now found toxicity. the and There CV participants, CBD, found and published the no
companies demonstrate completed the other Sciences containing as that safe. recognized have and sector studies extracts clearly CBD in be CV that can hemp generally
hemp-derived to proliferation continues In even of be of the number products with addition, adverse remarkably the market, the low. events in
e-tailers force companies be consumers standard this quality. to comply basic practices. be this can all make happen. that will protected on insist good regulation Federal manufacturing should that with ensure second Consumers The unsafe regulation An food quality. is in all means area expect they the is, from consumer supply. the trust insist that should Retailers, to products industry guiding critical and seeking
is, our consumers, mainstream, will further regulation help will investment product open to in improve our bring research, legitimize encourage third and to much area our confidence make and of will needed hemp-derived industry. regulation will category. federal available it that regulation a channels, more industry deliver The It safety ingredients and Federal expand future. to mean critical quality, create brighter will sales and
for see our industry, regulation at the and the we of promising absence state regulation both federal level. federal Despite
with other states the recently much positive. waiting, Certainly, we join federal eager would led needed legislation. the to XXX biggest California new require product The two At responsible are New level, H.R. and companies of which and as support ingredient for safety to utilizing would dietary have pathway the regulate markets, FDA the not process of dietary are way XXX. CBD York, industry demonstrate create is application to in supplement and a a H.R. participants quality.
to process immediately. DI the prepared begin dietary new ingredient are We and
improve summarize, To for a quality, safety, consumer ingredients future federal products. confidence regulation hemp-derived will brighter much create and and
industry. We are for much working regulatory state level the needed diligently and federal structure at both to advance our
locations key of retail cash environment over focused existing and initiatives, product cost Notwithstanding brand with lines, the new of sales with on implementation flow federal distribution expansion U.S. with BXB we a including: in continued measures of efficiency XXXX, positive. new regulation, X,XXX during future building lack introduction saturation and for and in achieve challenging several channels to
driving Our stemming product XXXX, focus on in environment headwinds the despite and helped of gains federal solid business broaden significant innovation regulation. our from absence pandemic, distribution quality competitive and
response response with As mentioned, introduced line, product support stress during their product And normal wellness new recently, new back launch our we lines our soreness. and to support inflammatory to helps people XXXX, in cycles Relief, newest that occasional sleep manage a our routines. several PlusCBD Sleep help line, healthy and starting and Calm gummies include wellness healthy our get to most which which
specifically We listen our customers. to products customers states our address need work the and needs hard their to carefully and that develop of
line practitioners' introduced OTC science-based line with products that leverage pain in approach products our CBD our and XXXX strength clinical a of targeting product relief of offering includes Another topical health care that products. strong consumers' available and line self-care through in sales products company. new medicine health natural channel are exclusively for includes our a interest strategic This alternative practitioners, plant-based
balanced Reserve that is intended of hemp offering the provide THC benefit that line spectrum a to last is and cannabinoids, I including CBD working cannabinoid synergistically Collection, for the mention And new PlusCBD will our full a supplement. product
our Relief growth. line revenue of strong The new pipeline capitalize topical Sleep, innovation opportunities to for and evidence are along OTC offering of products reserve with products, our and new pain wellness and on ability future relief Calm our
consumer of our the offering XX% base. for our trends revenue XXXX was ended indicated contribution XX, products launched December to since net product new our as XXXX. to needs new year critical, revenue is from product and Evolving by
meet develop to launch new of and innovate, continue customers. We the our products that will needs
product pipeline and company products innovative, high-quality, future the for we proven Our growth. include development will position believe is that
With products, studies, CBD for to continues billion benefit the we according to a addressable about plus $X industry The evolving as consolidation. total further remain a CBD and future repositioning, recent from as prospects. regulatory market optimistic well we expect to of our growth framework undergo
dynamics, also near-term competitive we challenges advance brand company continuing term, uncertainties, on initiatives. our and achieving and continuing cost cash Given to in CBD growth contraction and remain our our innovation to consolidation the participate and and positive positioned value. Despite the of current market to in initiatives on near shareholder have while to and driving the we long-term leveraging focused core the execute brand strategic drive market efficiency flow awareness advantages key by
Our priorities for reflect value on to XXXX delivering our our shareholders. focus
We of a business the taken and have any and a value sale, inbound outbound next whole commencing review, step segment. the acquisition includes shareholder improve consideration by or other merger, strategic which as company for for to options
company Partners, We have Alliance Global review. strategic engaged to with assist the the A.G.P.,
the through turn over now Joerg will run the to financials. call I to
